Related Experiment Video

Updated: May 26, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

252

KLF4: a multifunctional nexus connecting tumor progression and immune regulation

Yunjie Ju1, Wen Xiao1, Bryan James Mathis2

  • 1Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in Immunology
|February 25, 2025
PubMed

Insights

Krüppel-like factor 4 (KLF4) has a dual role in cancer, acting as both a tumor promoter and suppressor. Its overexpression enhances anti-tumor immunity by boosting CD8+ T cell differentiation.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • Krüppel-like factors (KLFs) are transcription factors regulating critical cellular processes.
  • KLF4's role in tumorigenesis is context-dependent, influencing inflammation and immune responses.
  • KLF4 can act as either a tumor promoter or a tumor suppressor.

Purpose of the Study:

  • To review the intricate relationship between KLF4, immunity, and cancer.
  • To elucidate the multifaceted roles of KLF4 in various tumor types and stages.
  • To provide insights for future research directions in KLF4-mediated cancer immunity.

Main Methods:

  • Literature review and synthesis of existing research on KLF4.
  • Analysis of KLF4's function in different cancer contexts.
  • Examination of KLF4's impact on immune cell differentiation and function.

Main Results:

  • KLF4 exhibits context-specific functions in cancer development.
  • KLF4 influences both pro-tumorigenic and anti-tumorigenic pathways.
  • Overexpression of KLF4 promotes CD8+ T cell differentiation, enhancing anti-tumor immunity.

Conclusions:

  • KLF4's complex role in immunity and cancer necessitates further investigation.
  • Understanding KLF4's dual function is crucial for developing novel cancer immunotherapies.
  • Targeting KLF4 pathways could offer new therapeutic strategies for cancer treatment.
Keywords:
KLF4immune regulationoncogenesistumor immunologytumor microenvironment (TME)

More Related Videos

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.5K
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.4K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
826
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K